期刊文献+

^18F-氟脱氧葡萄糖和^11C-胆碱在孤立性肺结节诊断中的应用 被引量:3

Diagnostic uses for ^18F-fluorodeoxyglucose and ^11C-choline in single pulmonary nodules
原文传递
导出
摘要 ^18F-.氟脱氧葡萄糖(^18F-FDG)和^11C-胆碱(^11C-choline)在孤立性肺结节(SPN)的定性诊断方面各有优势,两者联用可以互相弥补不足,效果较好。^18F-FDG对恶性SPN以及淋巴结转移判断的敏感性和特异性较高,^11C-胆碱可以降低炎性病变的假阳性率,有利于恶性SPN脑转移的诊断。但^11C-胆碱PET和^18F-FDGPET一样无法显示细支气管肺泡癌、小细胞肺癌等代谢较低的SPN。有报道,^18F-氟脱氧胸苷(^18F-FLT)可用于对肿瘤进行良恶性鉴别、疗效评估和预后判断,被认为是一种具有良好应用前景的PET显像剂。 For qualitation diagnosis of single pulmonary nodules (SPN), both ^18F-fluorodeoxyglueose ( ^18F-FDG)PET and ^11C-choline PET have their own advantages. The outcome of the PET imaging will have more value for diagnosis if the two agents are used. ^18F-FDG PET has more high sensitivity and specificity for diagnosis of malignant SPN and metastasis of lymphonodes, ^11C-choline PET can decrease the false positive rate of inflamed foei and is helpful to diagnosis of brain metastasis from the malignant SPN. However, both agents can't be accumulated in bronehioalveolar carcinoma and small lung cancer with lower metabolism. It is reported that 3'-deoxy-3'-^18F-fluorothymidine (^18F-FLT) PET can be used to detect the benign nodes from the malignanee, evaluate the therapeutic effect and prognosis.^18F-FLT may be a prospective PET tracer in clinical applieation.
作者 姜磊
出处 《国际放射医学核医学杂志》 2007年第1期28-30,共3页 International Journal of Radiation Medicine and Nuclear Medicine
关键词 氟脱氧葡萄糖F18 胆碱 孤立性肺结节 Fluorodeoxyglueose F18 Choline Single pulmonary nodules
  • 相关文献

参考文献16

二级参考文献48

  • 1马云川,张琳瑛,苏玉盛,李德鹏,尚建文.肺部病变^(18)F-FDG PET显像的适应证[J].中华核医学杂志,2003,23(S1):31-34. 被引量:6
  • 2中华医学会结核病学分会第七届委员会名单[J].中华结核和呼吸杂志,2004,27(12):800-800. 被引量:7
  • 3李家敏,孙启银,杨乃明,王明芳,黄术林,张登胜,赵军,孙爱君,李娜,黄少勇.^(18)F-FDG PET显像鉴别肺部单发肿块性质及肺癌分期的价值[J].中华核医学杂志,1997,17(2):77-79. 被引量:27
  • 4Dittmann H, Dohmen BM, Kehlbach R, et al. Early changes in [18F]FLT uptake after chemotherapy: an experimental study [J]. EurJ Nucl Med Mol Imaging, 2002, 29(11):1462-1469.
  • 5Dittmann H, Dohmen BM, Paulsen F, et al. [18F] FLT PET for diagnosis and staging of thoracic tumours [J]. Eur J Nucl Med Mol Imaging, 2003, 30( 10): 1407-1412.
  • 6Buck AK, Halter G, Schirrmeister H, et al. Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG [J]. J Nucl Med, 2003, 44(9): 1426-1431.
  • 7Wagner M, Seitz U, Neumaier B, et al. Evaluation of pyrimidine metabolising enzymes and in vitro uptake of 3′-
  • 8Wagner M, Seitz U, Buck A, et al. 3′-[18F]fluoro-3′-deoxythymidine ([18F]-FLT) as positron emission tomography tracer for imaging proliferation in a murine B-Cell lymphoma model and in the human disease [J]. Cancer Res 2003, 63( 10): 2681-2687.
  • 9Francis DL, Visvikis D, Costa DC, et al. Potential impact of[18F]3′-deoxy-3′-fluorothymidine versus [18F] fluoro-2-deoxy-D-glucose in positron emission tomography for colorectal cancer [J]. Eur J Nucl Med Mol Imaging, 2003, 30 (7):988-994.
  • 10Vesselle H, Grierson J, Muzi M, et al. In vivo validation of 3′-deoxy-3′-[18F]fluorothymidine ([18F] FLT) as a proliferation imaging tracer in humans: correlation of [18F] FLT uptake by positron emission tumography with Ki-67 immunohistochemistry and fl

共引文献56

同被引文献21

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部